Wins for AstraZeneca: Diabetes Drug Approved for Teens, Covid Vaccine Effective against Delta Variant

Wins for AstraZeneca: Diabetes Drug Approved for Teens, Covid Vaccine Effective against Delta Variant

Source: 
BioSpace
snippet: 

The FDA has now approved AstraZeneca's convenient once-a-week glucose lowering drug for 10 to 17-year-olds with type 2 diabetes. In a pivotal trial, the Bydureon BCise injection significantly reduced blood sugar in the adolescents receiving the drug, as measured by HbA1c.